D-SOLVE: Study of Hepatitis D treatments
Part of Digestive system, Infections clinical trials.
This trial is testing treatments for people with chronic hepatitis D, a serious liver infection. If you have antibodies to the hepatitis D virus (HDV), you may be able to join and help find better ways to manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have tested positive for antibodies that show you have been infected with the hepatitis D virus.
- You must be at least 18 years old.
- People of any sex or gender can join.
- You must be willing to agree to all study-related procedures after learning about them.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with hepatitis D who are taking the medication bulevirtide. It aims to find biological markers that may help track the disease and guide treatment.
This study uses a mobile diary app to track symptoms and quality of life for people living with hepatitis D infection. It may help researchers better understand the patient experience.
This study looks at patient information (your health data) for adults who test positive for HDV. You may help researchers better understand HDV by allowing their team to collect and use your data.
This study tests a new medicine called Hepalatide for people with chronic hepatitis D, a serious liver infection. It aims to see if the drug can reduce the virus and improve liver health. You may be eligible if you have both hepatitis B and D and are on stable hepatitis B treatment.
This study follows adults who have ongoing hepatitis D infection along with hepatitis B. It aims to better understand this mixed infection and how these patients do over time.
This study looks at people in China who have hepatitis D, a liver infection. It aims to learn more about the disease and how it affects people, which may help improve future care.
Hear when a new HDV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.